| |
| |
|
| Insider
Information: |
Eshelman Fredric N |
| Relationship: |
10% Owner |
| City: |
Wilmington |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
8,151,654 |
|
|
Indirect Shares
|
3,933,809 |
|
|
| Direct
Value |
$95,684,563 |
|
|
|
Indirect Value
|
$13,709,856 |
|
|
| Total
Shares |
12,085,463 |
|
|
| Total
Value |
$109,394,419 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
7
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
-7.0
|
-3.0
|
| Percentage
Gain/Loss : |
 -45.7%
|
-43.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmaceutical Product Developme... |
PPDI |
Executive Chairman, Di... |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
|
Furiex Pharmaceuticals, Inc. |
FURX |
Director, 10% Owner |
2014-07-02 |
0 |
2014-07-02 |
0 |
Premium* |
|
|
Bausch Health Companies Inc |
BHC |
Director |
2017-05-05 |
38,298 |
2016-03-11 |
0 |
Premium* |
|
|
G1 Therapeutics Inc |
GTHX |
Director, 10% Owner |
2017-11-13 |
250,000 |
2017-11-13 |
3,439,151 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
Director |
2020-09-11 |
1,292,787 |
2020-09-11 |
319,085 |
Premium* |
|
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2020-11-25 |
6,570,569 |
2020-11-25 |
175,573 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2011-12-05 |
4 |
D |
$33.25 |
$232,242,638 |
D/D |
(6,984,741) |
0 |
0 |
- |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-07-02 |
4 |
B |
$8.00 |
$15,000,000 |
D/D |
1,875,000 |
7,034,744 |
2.45 |
% |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2011-12-05 |
4 |
D |
$33.25 |
$13,547,480 |
I/I |
(407,443) |
0 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2005-07-20 |
4 |
S |
$59.96 |
$9,185,899 |
D/D |
(153,000) |
5,209,263 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• – – |
2006-05-15 |
4 |
S |
$36.45 |
$7,278,096 |
D/D |
(198,425) |
9,632,101 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • – |
2011-05-20 |
4 |
B |
$13.99 |
$6,505,350 |
D/D |
465,000 |
1,081,687 |
2.39 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2005-05-26 |
4 |
OE |
$6.53 |
$5,706,592 |
D/D |
380,000 |
5,362,263 |
|
- |
|
| GTHX |
G1 Therapeutics Inc |
Director |
– • • |
2017-11-13 |
4 |
B |
$19.73 |
$4,932,500 |
D/D |
250,000 |
250,000 |
3.92 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2005-07-21 |
4 |
S |
$59.40 |
$4,655,153 |
D/D |
(77,788) |
5,074,486 |
|
- |
|
| GTHX |
G1 Therapeutics Inc |
Director |
– • • |
2017-05-22 |
4 |
B |
$15.00 |
$4,500,000 |
I/I |
300,000 |
3,439,151 |
2.25 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • • |
2011-11-08 |
4 |
B |
$16.00 |
$4,000,000 |
D/D |
250,000 |
1,610,273 |
3.92 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • – |
2011-05-25 |
4 |
B |
$15.35 |
$3,837,500 |
D/D |
250,000 |
1,346,203 |
2.39 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2005-07-21 |
4 |
S |
$59.51 |
$3,401,213 |
D/D |
(56,989) |
5,152,274 |
|
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • • |
2018-01-29 |
4 |
B |
$10.00 |
$3,350,000 |
D/D |
335,000 |
1,273,428 |
3.92 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2005-07-22 |
4 |
S |
$59.03 |
$3,250,299 |
D/D |
(54,601) |
4,980,210 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-04-02 |
4 |
S |
$33.40 |
$2,799,552 |
D/D |
(83,333) |
8,933,960 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2008-05-20 |
4 |
S |
$42.63 |
$2,785,830 |
D/D |
(65,220) |
8,018,626 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-03-19 |
4 |
S |
$31.41 |
$2,629,611 |
D/D |
(83,034) |
9,017,593 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2006-05-16 |
4 |
S |
$36.07 |
$2,608,273 |
D/D |
(72,045) |
9,505,481 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-05-14 |
4 |
S |
$33.48 |
$2,497,943 |
D/D |
(74,334) |
8,692,960 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2005-07-21 |
4 |
S |
$59.26 |
$2,325,274 |
D/D |
(38,976) |
5,034,811 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2006-05-16 |
4 |
S |
$36.38 |
$2,293,378 |
D/D |
(62,775) |
9,442,706 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-06-01 |
4 |
S |
$36.39 |
$2,273,094 |
D/D |
(61,792) |
8,622,168 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-05-01 |
4 |
S |
$35.03 |
$2,229,681 |
D/D |
(63,433) |
8,768,194 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-06-18 |
4 |
S |
$36.56 |
$2,036,971 |
D/D |
(55,382) |
8,545,145 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
